Skip to content
agt-logo-redirect-page

Menu

  • Mission
  • Pipeline
    • Overview
    • HIV
    • Phenylketonuria (PKU)
    • Immuno-Oncology
  • About Us
    • Leadership Team
    • In Memoriam: Dr. Roscoe Brady
    • History

Methods of Producing Cells Resistant to HIV Infection

Read More

Non-Integrating Viral Delivery System and Methods of Use Thereof

Read More

HIV Pre-Immunization and Immunotherapy JP

Read More

Immunotherapy, No Pre-Immunization, HIV(+) Patients KR

Read More

Immunotherapy, No Pre-Immunization, HIV(+) Patients JP

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients JP

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients IL

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients IL

Read More
« Newer Posts
Older Posts »

Follow AGT on Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

AGT on Facebook

This message is only visible to admins.
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Error: Error validating access token: The session has been invalidated because the user changed their password or Facebook has changed the session for security reasons. Type: OAuthException

Get In Touch

American Gene Technologies Inc.

Rockville, Maryland

Phone: (301) 337-2100

Follow Us on Social Media

Contact Us

info@americangene.com

Follow Us on Social Media

Copyright © 2025 American Gene Technologies® | Privacy Policy

  • Mission
  • Pipeline
    • Overview
    • HIV
    • Phenylketonuria (PKU)
    • Immuno-Oncology
    • Back
  • About Us
    • Leadership Team
    • In Memoriam: Dr. Roscoe Brady
    • History
    • Back
Scroll To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy